Terms: = Head and neck cancer AND NAB2, MADER, 4665, ENSG00000166886, Q15742, MGC75085 AND Treatment
3 results:
1. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone administration for adjuvant therapy in patients with intermediate- to high-risk differentiated thyroid cancer.
Iizuka Y; Katagiri T; Ogura K; Inoue M; Nakamura K; Mizowaki T
Ann Nucl Med; 2020 Oct; 34(10):736-741. PubMed ID: 32643022
[TBL] [Abstract] [Full Text] [Related]
3. Preferences for the Provision of Smoking Cessation Education Among cancer Patients.
Sampson L; Papadakos J; Milne V; Le LW; Liu G; Abdelmutti N; Milne R; Goldstein DP; Eng L; Giuliani M
J Cancer Educ; 2018 Feb; 33(1):7-11. PubMed ID: 27075196
[TBL] [Abstract] [Full Text] [Related]